BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1748470)

  • 1. Carrier-induced suppression of the antibody response to a 'self' hapten.
    Sad S; Gupta HM; Talwar GP; Raghupathy R
    Immunology; 1991 Oct; 74(2):223-7. PubMed ID: 1748470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bypass of carrier-induced epitope-specific suppression using a T-helper epitope.
    Sad S; Rao K; Arora R; Talwar GP; Raghupathy R
    Immunology; 1992 Aug; 76(4):599-603. PubMed ID: 1383134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier-induced epitope-specific regulation and its bypass in a protein-protein conjugate.
    Kaliyaperumal A; Chauhan VS; Talwar GP; Raghupathy R
    Eur J Immunol; 1995 Dec; 25(12):3375-80. PubMed ID: 8566026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyporesponsiveness to a GnRH vaccine in a non-responder mouse strain is T-cell mediated.
    Sad S; Gupta HM; Talwar GP; Raghupathy R
    J Reprod Immunol; 1991 Jul; 20(2):189-94. PubMed ID: 1753388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier-induced epitopic suppression is initiated through clonal dominance.
    Schutze MP; Deriaud E; Przewlocki G; LeClerc C
    J Immunol; 1989 Apr; 142(8):2635-40. PubMed ID: 2467933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the genetic background and carrier protein on the antibody response to GnRH.
    Sad S; Talwar GP; Raghupathy R
    J Reprod Immunol; 1991 Feb; 19(2):197-207. PubMed ID: 2008003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an anti-fertility vaccine based on mammalian gonadotrophin releasing hormone (GnRH-I)--a histological comparison in male animals.
    Ferro VA; Khan MA; McAdam D; Colston A; Aughey E; Mullen AB; Waterston MM; Harvey MJ
    Vet Immunol Immunopathol; 2004 Sep; 101(1-2):73-86. PubMed ID: 15261694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells.
    Daniel PT; Krammer PH
    J Immunol; 1994 Jun; 152(12):5624-32. PubMed ID: 7515909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic gonadotrophin-releasing hormone (GnRH) vaccines incorporating GnRH and synthetic T-helper epitopes.
    Sad S; Chauhan VS; Arunan K; Raghupathy R
    Vaccine; 1993; 11(11):1145-50. PubMed ID: 7504380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two GnRH-I based vaccine formulations on the testes function of entire Suffolk cross ram lambs.
    Earl ER; Waterston MM; Aughey E; Harvey MJ; Matschke C; Colston A; Ferro VA
    Vaccine; 2006 Apr; 24(16):3172-83. PubMed ID: 16483697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adjuvant, dose and carrier pre-sensitisation on the immunisation efficacy of a GnRH analogue.
    Ferro VA; Stimson WH
    Drug Des Discov; 1996 Dec; 14(3):179-95. PubMed ID: 9017362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the reproductive system of male mice immunized with a GnRH-analogue conjugated to mycobacterial hsp70.
    Hannesdóttir SG; Han X; Lund T; Singh M; Van Der Zee R; Roitt IM; Delves PJ
    Reproduction; 2004 Sep; 128(3):365-71. PubMed ID: 15333787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
    Lum LG; Culbertson NJ
    J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunospecificity and affinity studies on anti-luteinizing hormone releasing hormone antibodies developed by azo-LHRH-TT and azo-LHRH-BSA conjugates.
    Singh V
    Biochem Int; 1992 Aug; 27(4):591-9. PubMed ID: 1417894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of carrier proteins on the immunologic response to haptenic antitetrodotoxin vaccine.
    Xu QH; Zhao XN; Cheng JP; Wei CH; Zhang QH; Rong KT
    Bioconjug Chem; 2006; 17(6):1508-13. PubMed ID: 17105230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyspecific human and murine antibodies to diphtheria and tetanus toxoids and phospholipids.
    Sutjita M; Hohmann A; Comacchio R; Bradley J
    Clin Exp Immunol; 1988 Aug; 73(2):191-7. PubMed ID: 3263226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant luteinising-hormone-releasing-hormone immunogen bioeffective in causing prostatic atrophy.
    Talwar GP; Raina K; Gupta JC; Ray R; Wadhwa S; Ali MM
    Vaccine; 2004 Sep; 22(27-28):3713-21. PubMed ID: 15315851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
    Gupta RK; Griffin P; Rivera R; Siber GR
    Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells specific to hapten carrier but not to carrier alone assist in the production of anti-hapten and anti-carrier antibodies.
    Shimizu T; Osaka Y; Banri-Koike C; Yoshida M; Endo K; Furukawa K; Oda M; Murakami A; Ogawa S; Abe R; Azuma T
    Int Immunol; 2007 Oct; 19(10):1157-64. PubMed ID: 17881502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
    Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
    Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.